Paperpal Prime Logo

Cardio-Oncology : Impact Factor & More

eISSN: 2057-3804pISSN: 2057-3804
JournalOpen Access

Key Metrics

CiteScore
2.3
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cardio-Oncology

Cardio-Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2090 | USD 2490 | GBP 1690
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Cardio-Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cardio-Oncology

Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy
  • 30 Jul 2026
  • Cardio-oncology
ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care: a retrospective ICU cohort study.
  • 21 Jul 2026
  • Cardio-oncology (London, England)
Interpretable machine learning for cardiovascular disease risk prediction in cancer survivors: development and internal validation.
  • 20 Jul 2026
  • Cardio-oncology (London, England)
The risk of myocardial infarction and ischemic stroke in pelvic cancer surgery.
  • 16 Jul 2026
  • Cardio-oncology (London, England)
Mortality predictors in cancer patients undergoing transcatheter aortic valve implantation for aortic stenosis: a systematic review and meta-analysis.
  • 16 Jul 2026
  • Cardio-oncology (London, England)
No detectable early subclinical cardiotoxicity within 12 weeks of thoracic radiotherapy under predominantly low cardiac dose exposure: a prospective cohort study.
  • 16 Jul 2026
  • Cardio-oncology (London, England)
Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy
  • 30 Jul 2026
  • Cardio-oncology
ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care: a retrospective ICU cohort study.
  • 21 Jul 2026
  • Cardio-oncology (London, England)
Interpretable machine learning for cardiovascular disease risk prediction in cancer survivors: development and internal validation.
  • 20 Jul 2026
  • Cardio-oncology (London, England)
The risk of myocardial infarction and ischemic stroke in pelvic cancer surgery.
  • 16 Jul 2026
  • Cardio-oncology (London, England)
Mortality predictors in cancer patients undergoing transcatheter aortic valve implantation for aortic stenosis: a systematic review and meta-analysis.
  • 16 Jul 2026
  • Cardio-oncology (London, England)
No detectable early subclinical cardiotoxicity within 12 weeks of thoracic radiotherapy under predominantly low cardiac dose exposure: a prospective cohort study.
  • 16 Jul 2026
  • Cardio-oncology (London, England)

FAQs on Cardio-Oncology